Navigation Links
BI-Clinical Offers 100% Coverage of All ACO Quality Measures Released by CMS
Date:11/22/2011

PRINCETON, New Jersey, November 22, 2011 /PRNewswire/ --

CitiusTech announced today that its BI-Clinical platform for healthcare business intelligence and advanced analytics supports all ACO quality measures that are part of the ACO final rule released by CMS on October 20, 2011.

BI-Clinical can now help ACO participants assess and report performance and quality of care, across all four domains - patient / caregiver experience, care coordination / patient safety, preventive health and at-risk population. With customizable interfaces, gaps-in-care reports, clinical alerts and comparative care-cost benchmarking, BI-Clinical enables ACOs to effectively manage quality of care for its patients, at both the individual as well as population level. BI-Clinical's flexible Clinical Measure Processing Engine enables ACOs to modify clinical measures and create new measures to effectively manage performance.

Dennis Swarup, Business Director at CitiusTech, highlighted, "Most ACOs will include hospitals with different EMRs, clinical applications, revenue cycle applications and financial systems. BI-Clinical's ability to support both claim and EHR data in a multi-vendor environment is key to addressing the ACOs' cross-enterprise reporting and performance management needs."

BI-Clinical has strong professional services partners across North America, who enable ACO participants to define their overall BI/analytics and reporting strategy for all stakeholders. Our partners also implement BI-Clinical and integrate the platform with ACO and hospital IT environments.

About BI-Clinical

CitiusTech's BI-Clinical is a modular, scalable and interoperable platform for healthcare BI, analytics and regulatory compliance. With over 600 pre-built measures and KPIs for clinical, financial, operational and regulatory reporting, BI-Clinical ensures 100% coverage of all Meaningful Use, PQRS, HEDIS, JCAHO and ACO quality reporting measures. BI-Clinical 10.3 is
'/>"/>

SOURCE CitiusTech Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology news :

1. Novel monoclonal antibody offers potential treatment for tumors resistant to VEGF therapy
2. Ultrathin flexible brain implant offers unique look at seizures in NIH-funded research
3. New report offers broad approach to assessing impacts of ecological damage
4. Evolution offers clues to leading cause of death during childbirth
5. Fiery volcano offers geologic glimpse into land that time forgot
6. Frost & Sullivan Recognizes M2SYS for its Path-Breaking Hybrid Biometric Platform(TM) That Offers Unparalleled Flexibility to End-Users
7. Frost & Sullivan Recognizes M2SYS for its Path-Breaking Hybrid Biometric Platform™ That Offers Unparalleled Flexibility to End-Users
8. New technology offers the next generation of mammography
9. New class of stem cell-like cells discovered offers possibility for spinal cord repair
10. Novel drug combination offers therapeutic promise for hard-to-treat cancers
11. Research offers means to detoxify mycotoxin-contaminated grain intended for ethanol, animal feed
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... , Dec. 15, 2014 The Defense Logistics ... to detect and prevent counterfeit microcircuits from entering into ... performing an in-house microcircuit anti-counterfeit initiative dubbed DNA marking. ... while increasing their reliability throughout the supply chain. The ...
(Date:12/17/2014)... , Dec. 16, 2014 Research and Markets ... the "Global Chemical Sensor Market 2015-2019" report ... One major trend upcoming in this ... biomedical applications. Chemical sensors help in recording of patient ...
(Date:12/11/2014)... Dec. 09, 2014 Research and Markets ... http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has announced the addition of the ... their offering. One major trend emerging ... advances in technology, it is important to upgrade biometric ...
Breaking Biology News(10 mins):Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... 11, 2010) Van Andel Research Institute (VARI) ... cells that line and protect the prostate in relation to ... that normal cells and cancer cells depend on different factors ... cancer cells without affecting normal cells when developing treatments. ...
... In its collective efforts to develop new drugs, the ... on the application of natural biological transformation processes. One ... microorganisms or cells in a bioreactor filled with a ... especially strict regulations, the conditions inside the bioreactor need ...
... When conditions become complicated, there is no choice but ... Some of them growing in mining areas have unusual strengths, ... and knowing how to deal with this. Based on this ... as medicinal herbs for contaminated soils. The current level ...
Cached Biology News:VAI researchers develop tool to help study prostate cancer 2Clean sampling from bioreactors 2Plants in mining areas can cure soil affected by contamination in very short time 2Plants in mining areas can cure soil affected by contamination in very short time 3
(Date:1/22/2015)... Denville, NJ (PRWEB) January 22, 2015 ... shearing technologies such as the Bioruptor® and complete ... semi-automation system for chromatin immunoprecipitation, alleviating the need ... reagents and controls needed for ChIP of histones ...
(Date:1/22/2015)...   Cypher Genomics, Inc., the leading genome ... SQNM ), the leading molecular diagnostics company, today ... prenatal tests (NIPT). Through this agreement, Sequenom will ... advance analysis of clinically-relevant fetal sub-chromosomal variants detected ...
(Date:1/22/2015)... , Jan. 22, 2015   GenoSpace , a precision ... tools to enable the broad use of genomic, imaging and ... the appointment of Michelle Munson , CEO of Aspera, ... Logo - http://photos.prnewswire.com/prnh/20150122/170713 ...
(Date:12/25/2014)... The report “Service Quality Management and Telco ... Type - Global Advancements, Worldwide Forecasts & Analysis (2014-2019)” ... and forecasting of revenues. , Browse 152 market ... in-depth TOC on “Service Quality Management (SQM) and Telco ...
Breaking Biology Technology:Diagenode Launches Unique Semi-Automated Solution for Chromatin Immunoprecipitation 2Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4GenoSpace Expands Board with Appointment of Michelle Munson 2Service Quality Management Market worth $2.1 Billion & Telco Customer Experience Management Market worth $2.3 Billion by 2019 – New Report by MarketsandMarkets 2Service Quality Management Market worth $2.1 Billion & Telco Customer Experience Management Market worth $2.3 Billion by 2019 – New Report by MarketsandMarkets 3Service Quality Management Market worth $2.1 Billion & Telco Customer Experience Management Market worth $2.3 Billion by 2019 – New Report by MarketsandMarkets 4
... EntreMed, Inc.,(Nasdaq: ENMD ), a clinical-stage pharmaceutical ... inflammatory diseases, today,reported results for the three- and ... http://www.newscom.com/cgi-bin/prnh/20010620/ENMDLOGO ), Revenues for the third ... comparable period a year ago. The Company,reported a ...
... TNS Recovery Complex(R) and APS Corrective Complex(TM)-, ... Improvements in Skin Elasticity-, CARLSBAD, Calif., ... recent launch of TNS Essential Serum(TM) a ... two,cutting-edge treatments, TNS Recovery Complex(R) and APS ...
... New labeling reinforces strong safety profile of Ranexa ... a.m. ET/5:00 a.m. PT -, PALO ALTO, ... CVTX ) announced today that the U.S. Food ... line indication for,Ranexa(R) (ranolazine extended-release tablets) for the ...
Cached Biology Technology:EntreMed Reports Third Quarter 2008 Financial Results 2EntreMed Reports Third Quarter 2008 Financial Results 3EntreMed Reports Third Quarter 2008 Financial Results 4EntreMed Reports Third Quarter 2008 Financial Results 5SkinMedica Launches TNS Essential Serum(TM) 2SkinMedica Launches TNS Essential Serum(TM) 3FDA Approves Ranexa(R) for First Line Anti Anginal Use and Adds New Claims for Reduction of Ventricular Arrhythmias, Bradycardia, New Atrial Fibrillation and HbA1c 2FDA Approves Ranexa(R) for First Line Anti Anginal Use and Adds New Claims for Reduction of Ventricular Arrhythmias, Bradycardia, New Atrial Fibrillation and HbA1c 3FDA Approves Ranexa(R) for First Line Anti Anginal Use and Adds New Claims for Reduction of Ventricular Arrhythmias, Bradycardia, New Atrial Fibrillation and HbA1c 4FDA Approves Ranexa(R) for First Line Anti Anginal Use and Adds New Claims for Reduction of Ventricular Arrhythmias, Bradycardia, New Atrial Fibrillation and HbA1c 5